MERS-CoV: Understanding the Latest Human Coronavirus Threat
Top Cited Papers
Open Access
- 24 February 2018
- Vol. 10 (2), 93
- https://doi.org/10.3390/v10020093
Abstract
Human coronaviruses cause both upper and lower respiratory tract infections in humans. In 2012, a sixth human coronavirus (hCoV) was isolated from a patient presenting with severe respiratory illness. The 60-year-old man died as a result of renal and respiratory failure after admission to a hospital in Jeddah, Saudi Arabia. The aetiological agent was eventually identified as a coronavirus and designated Middle East respiratory syndrome coronavirus (MERS-CoV). MERS-CoV has now been reported in more than 27 countries across the Middle East, Europe, North Africa and Asia. As of July 2017, 2040 MERS-CoV laboratory confirmed cases, resulting in 712 deaths, were reported globally, with a majority of these cases from the Arabian Peninsula. This review summarises the current understanding of MERS-CoV, with special reference to the (i) genome structure; (ii) clinical features; (iii) diagnosis of infection; and (iv) treatment and vaccine development.Keywords
Other Versions
Funding Information
- National Research Foundation (105836)
This publication has 186 references indexed in Scilit:
- Engineering a Replication-Competent, Propagation-Defective Middle East Respiratory Syndrome Coronavirus as a Vaccine CandidatemBio, 2013
- Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirusProceedings of the National Academy of Sciences of the United States of America, 2013
- A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoVVirology Journal, 2013
- MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatmentJournal of General Virology, 2013
- Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in HumansmBio, 2012
- Resveratrol exhibits a strong cytotoxic activity in cultured cells and has an antiviral action against polyomavirus: potential clinical useJournal of Experimental & Clinical Cancer Research, 2009
- Systematic Assembly of a Full-Length Infectious Clone of Human Coronavirus NL63Journal of Virology, 2008
- Vaccines to prevent severe acute respiratory syndrome coronavirus-induced diseaseVirus Research, 2008
- Role of Cell Culture for Virus Detection in the Age of TechnologyClinical Microbiology Reviews, 2007
- Emerging Respiratory Viruses: Challenges and Vaccine StrategiesClinical Microbiology Reviews, 2006